Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS) - Concepedia

Concepedia

Publication | Open Access

Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)

DOI Full Paper Access

15

Citations

29

References

2023

Year

Alyssa A Toorop, Zoë YGJ van Lierop, Liza M. Y. Gelissen, Elske Hoitsma, Esther Zeinstra, Luuk C van Rooij, Caspar E.P. van Munster, Anke Vennegoor, Jop Mostert, Beatrijs Wokke,

Journal of Neurology Neurosurgery & Psychiatry

Abstract

NCT04225312.

References

	Year	Citations

Page 1